Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.wanbury.com | |
Market Cap | 477.59 Cr. | |
Enterprise Value(EV) | 572.58 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 7.13 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 20.47 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -3.73 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -39.14 | Calculated using Price: 145.85 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 3.27 Cr. | 32,745,498 Shares |
FaceValue | 10 | |
About Wanbury Ltd. | ||
Wanbury was incorporated in 1990 as a private limited company under the name of Pearl Distributors Private Limited. The name of the company was changed to 'Pearl Organics Private Limited on January 17, 1991 and the company was converted into a public limited company on August 6, 1991. |
1 Day |
|
+2.47% |
1 Week |
|
+12.58% |
1 Month |
|
-17.61% |
3 Month |
|
+9.27% |
6 Month |
|
+116.10% |
1 Year |
|
+277.70% |
2 Year |
|
+60.75% |
5 Year |
|
+513.11% |
10 Year |
|
+568.20% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | 13.85 | 15.27 | 70.48 | -2 | 50.26 | 444.45 | 87.61 | 428.78 | 29.82 | |
Return on Assets (%) | 0.8 | -1.82 | 15.57 | -9.44 | -9 | 23.1 | -4.51 | 25.85 | -3.22 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -194 | -189 | -153 | -185 | -209 | -143 | -156 | -23 | -33 | -22 | |
Non Curr. Liab. | 298 | 251 | 160 | 106 | 130 | 108 | 84 | 11 | 11 | 110 | |
Curr. Liab. | 265 | 299 | 402 | 348 | 362 | 311 | 355 | 360 | 320 | 253 | |
Minority Int. | 27 | 27 | |||||||||
Equity & Liab. | 396 | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 298 | 341 | |
Non Curr. Assets | 215 | 224 | 217 | 192 | 185 | 182 | 182 | 174 | 174 | 184 | |
Curr. Assets | 181 | 164 | 192 | 78 | 98 | 94 | 98 | 171 | 122 | 157 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 396 | 388 | 409 | 269 | 283 | 275 | 284 | 347 | 298 | 341 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 250 | 423 | 434 | 371 | 391 | 367 | 393 | 511 | 500 | 569 | |
Other Income | 6 | 1 | 90 | 77 | 12 | 46 | 5 | 5 | 1 | ||
Total Income | 256 | 425 | 524 | 448 | 403 | 414 | 397 | 516 | 501 | 569 | |
Total Expenditure | -229 | -391 | -415 | -439 | -378 | -389 | -377 | -479 | -477 | -503 | |
PBIDT | 28 | 34 | 108 | 9 | 25 | 25 | 20 | 37 | 24 | 66 | |
Interest | -19 | -32 | -36 | -31 | -40 | -33 | -23 | -21 | -21 | -29 | |
Depreciation | -5 | -9 | -10 | -10 | -10 | -10 | -10 | -11 | -12 | -13 | |
Taxation | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Exceptional Items | 83 | 76 | -1 | -1 | |||||||
PAT | 3 | -7 | 62 | -32 | -25 | 64 | -13 | 81 | -10 | 23 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 3 | -7 | 62 | -32 | -25 | 64 | -13 | 81 | -10 | 23 | |
Adjusted EPS | 2 | -4 | 27 | -13 | -10 | 26 | -5 | 25 | -3 | 7 |
Particulars | 10 years | 2014-09 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 68 | 40 | 43 | 43 | 32 | 30 | 44 | 17 | 41 | 20 | |
Cash Fr. Inv. | -6 | -5 | -20 | -13 | -1 | -3 | 64 | 8 | 1 | -9 | |
Cash Fr. Finan. | -71 | -30 | -28 | -27 | -33 | -27 | -108 | -17 | -29 | -32 | |
Net Change | -9 | 5 | -5 | 3 | -2 | 0 | 0 | 7 | 13 | -21 | |
Cash & Cash Eqvt | 1 | 6 | 2 | 5 | 3 | 3 | 3 | 10 | 23 | 1 |
Fri, 29 Mar 2024
Closure of Trading Window The Company has informed the Exchange about the Closure of Trading Window for the quarter and year ended 31st March 2024 from 01st April 2024 upto 48 hrs. from the declaration of Audited Financial Results for the quarter and year ended 31st March 2024 |
Wed, 27 Mar 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Schedule of Analyst/Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Fri, 22 Mar 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Expert Chemicals India Pvt Ltd |
Thu, 28 Mar 2024 |
Close Crossing Last Week High |
Opening at Low |
Close Above Last Week High |
Making Lower Lows for 2 Days |
High Decrease in 1 Month |